EUCTR2009-011679-65-IT
进行中（未招募）
不适用
A Long Term, Open Labeled Study with Teduglutide for Subjects with Parenteral Nutrition-Dependent Short Bowel Syndrome who completed Study Cl0600020 - Cl0600021
PS PHARMACEUTICALS0 个研究点目标入组 66 人2010年3月11日
概览
- 阶段
- 不适用
- 干预措施
- 未指定
- 疾病 / 适应症
- Short Bowel Syndrome
- 发起方
- PS PHARMACEUTICALS
- 入组人数
- 66
- 状态
- 进行中（未招募）
- 最后更新
- 12年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •1\. Completion of 24\-weeks of dosing in Study CL0600\-020\.
- •2\. Signed and dated informed consent form (ICF) to participate before any study\-related procedures of Study
- •CL0600\-021 are performed.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range
- •F.1\.3 Elderly (\>\=65 years) yes
- •F.1\.3\.1 Number of subjects for this age range
排除标准
- •Exclusion criteria do not apply as all subjects who completed 24 weeks of dosing in Study CL0600\-020 are
- •qualified to enter this study.
结局指标
主要结局
未指定
相似试验
进行中（未招募）
不适用
A Long Term, Open Label Study with Teduglutide for Subjects with Parenteral Nutrition Dependent Short Bowel Syndrome Estudio a largo plazo y en régimen abierto de teduglutida en sujetos con síndrome del intestino corto dependientes de nutrición parenteralShort Bowel SyndromeSindrome de Intestino CortoMedDRA version: 12.0Level: LLTClassification code 10049416Term: <Manually entered code. Term in E.1.1>EUCTR2009-011679-65-ESPS Pharmaceuticals, Inc.86
进行中（未招募）
不适用
A Long Term, Open Label Study with Teduglutide for Subjects with Parenteral Nutrition Dependent Short Bowel SyndromeEUCTR2009-011679-65-DKPS Pharmaceuticals, Inc.84
进行中（未招募）
不适用
A Long Term, Open Label Study with Teduglutide for Subjects with Parenteral Nutrition Dependent Short Bowel SyndromeShort Bowel SyndromeMedDRA version: 14.1Level: PTClassification code 10049416Term: Short-bowel syndromeSystem Organ Class: 10017947 - Gastrointestinal disordersTherapeutic area: Diseases [C] - Digestive System Diseases [C06]EUCTR2009-011679-65-DEPS Pharmaceuticals, Inc.84
进行中（未招募）
1 期
A Long Term, Open Label Study with Teduglutide for Subjects with Parenteral Nutrition Dependent Short Bowel SyndromeShort Bowel SyndromeMedDRA version: 14.1 Level: PT Classification code 10049416 Term: Short-bowel syndrome System Organ Class: 10017947 - Gastrointestinal disordersTherapeutic area: Diseases [C] - Digestive System Diseases [C06]EUCTR2009-011679-65-GBPS Pharmaceuticals84
进行中（未招募）
1 期
A Long Term, Open Label Study with Teduglutide for Subjects with Parenteral Nutrition Dependent Short Bowel SyndromeShort Bowel SyndromeMedDRA version: 12.0Level: LLTClassification code 10049416Term: <Manually entered code. Term in E.1.1>EUCTR2009-011679-65-FRPS Pharmaceuticals, Inc.84